Neurocrine Biosciences Revenue 2006-2019 | NBIX

Neurocrine Biosciences annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Neurocrine Biosciences revenue for the quarter ending June 30, 2019 was $0.184B, a 89.44% increase year-over-year.
Neurocrine Biosciences revenue for the twelve months ending June 30, 2019 was $0.605B, a 87.21% increase year-over-year.
Neurocrine Biosciences annual revenue for 2018 was $0.451B, a 179.19% increase from 2017.
Neurocrine Biosciences annual revenue for 2017 was $0.162B, a 977.51% increase from 2016.
Neurocrine Biosciences annual revenue for 2016 was $0.015B, a 24.12% decline from 2015.

Neurocrine Biosciences Annual Revenue (Millions of US $)
2018	$451
2017	$162
2016	$15
2015	$20
2014	$
2013	$3
2012	$53
2011	$77
2010	$34
2009	$3
2008	$4
2007	$1
2006	$39
2005	$124

Neurocrine Biosciences Quarterly Revenue (Millions of US $)
Q2 2019	$184
Q1 2019	$138
Q4 2018	$131
Q3 2018	$152
Q2 2018	$97
Q1 2018	$71
Q4 2017	$95
Q3 2017	$61
Q2 2017	$6
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016	$15
Q4 2015
Q3 2015
Q2 2015
Q1 2015	$20
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013	$1
Q3 2013	$1
Q2 2013	$1
Q1 2013	$1
Q4 2012	$22
Q3 2012	$9
Q2 2012	$11
Q1 2012	$11
Q4 2011	$11
Q3 2011	$42
Q2 2011	$12
Q1 2011	$13
Q4 2010	$14
Q3 2010	$14
Q2 2010	$5
Q1 2010	$1
Q4 2009	$1
Q3 2009	$1
Q2 2009	$1
Q1 2009	$1
Q4 2008	$1
Q3 2008	$1
Q2 2008	$1
Q1 2008	$2
Q4 2007	$1
Q3 2007	$1
Q2 2007	$0
Q1 2007	$0
Q4 2006	$9
Q3 2006	$1
Q2 2006	$9
Q1 2006	$19
Q4 2005	$14
Q3 2005	$65
Q2 2005	$33
Q1 2005	$12

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$8.689B	$0.451B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$59.064B	36.38
Takeda Pharmaceutical (TAK)	Japan	$26.341B	8.22
Astellas Pharma (ALPMY)	Japan	$26.215B	12.85
UCB SA (UCBJF)	Belgium	$15.008B	0.00
Grifols, S.A (GRFS)	Spain	$15.002B	19.14
Eisai (ESALY)	Japan	$14.332B	24.64
Merck (MKGAF)	Germany	$13.654B	18.63
Ionis Pharmaceuticals (IONS)	United States	$9.481B	20.45
Ono Pharmaceutical (OPHLF)	Japan	$9.383B	20.06
IPSEN SA ADR (IPSEY)	France	$8.520B	0.00
Sage Therapeutics (SAGE)	United States	$8.318B	0.00
Catalent (CTLT)	United States	$8.054B	32.32
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.439B	9.79
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$7.257B	19.83
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$5.781B	0.00
STADA ARZNEIMI (STDAF)	Germany	$5.547B	0.00
Orion OYJ (ORINY)	Finland	$5.275B	27.16
Hypermarcas (HYPMY)	Brazil	$4.735B	17.02
FibroGen (FGEN)	United States	$3.750B	93.78
United Therapeutics (UTHR)	United States	$3.487B	0.00
Tilray (TLRY)	Canada	$3.415B	0.00
Nektar Therapeutics (NKTR)	United States	$3.188B	0.00
Evotec AG (EVTCY)	Germany	$3.120B	42.71
Taro Pharmaceutical Industries (TARO)	Israel	$3.103B	11.12
Arrowhead Pharmaceuticals (ARWR)	United States	$2.767B	63.44
PTC Therapeutics (PTCT)	United States	$2.614B	0.00
Xencor (XNCR)	United States	$2.284B	49.79
Portola Pharmaceuticals (PTLA)	United States	$2.085B	0.00
Zogenix (ZGNX)	United States	$2.057B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.621B	59.00
CLINIGEN GP (CLIGF)	United Kingdom	$1.577B	0.00
USANA Health Sciences (USNA)	United States	$1.452B	14.56
Corcept Therapeutics (CORT)	United States	$1.439B	19.78
Ironwood Pharmaceuticals (IRWD)	United States	$1.404B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$1.384B	22.84
Heron Therapeutics (HRTX)	United States	$1.349B	0.00
Theravance Biopharma (TBPH)	Cayman Islands	$1.205B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.129B	0.00
Radius Health (RDUS)	United States	$1.040B	0.00
ArQule (ARQL)	United States	$1.039B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$0.837B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$0.718B	3.20
TherapeuticsMD (TXMD)	United States	$0.716B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.552B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.545B	0.00
Concordia (CXRXF)	Canada	$0.533B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.518B	0.00
Akebia Therapeutics (AKBA)	United States	$0.511B	0.00
Endo (ENDP)	Ireland	$0.505B	0.89
Aptorum Group (APM)	China	$0.477B	0.00
Indivior (INVVY)	United States	$0.466B	1.68
Crinetics Pharmaceuticals (CRNX)	United States	$0.437B	0.00
Dermira (DERM)	United States	$0.430B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.427B	0.00
BioSpecifics Technologies Corp (BSTC)	United States	$0.421B	19.12
ImmunoGen (IMGN)	United States	$0.412B	0.00
Siga Technologies (SIGA)	United States	$0.411B	0.96
Flexion Therapeutics (FLXN)	United States	$0.409B	0.00
Translate Bio (TBIO)	United States	$0.405B	0.00
ChemoCentryx (CCXI)	United States	$0.376B	0.00
Innate Pharma SA (IPHYF)	France	$0.374B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.366B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.354B	0.00
Organogenesis Holdings (ORGO)	United States	$0.326B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.322B	0.00
CV Sciences (CVSI)	United States	$0.317B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.292B	0.00
Harpoon Therapeutics (HARP)	United States	$0.286B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$0.285B	0.00
CannTrust Holdings (CTST)	Canada	$0.280B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.280B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.256B	0.00
Lannett Co Inc (LCI)	United States	$0.255B	2.48
DURECT (DRRX)	United States	$0.250B	0.00
OptiNose (OPTN)	United States	$0.249B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.244B	0.00
Recro Pharma (REPH)	United States	$0.241B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.219B	0.00
Calithera Biosciences (CALA)	United States	$0.210B	0.00
Ocular Therapeutix (OCUL)	United States	$0.199B	0.00
Molecular Templates (MTEM)	United States	$0.186B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.176B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.176B	0.00
Taiwan Liposome (TLC)	Taiwan	$0.175B	0.00
Nature's Sunshine Products (NATR)	United States	$0.174B	29.03
Redhill Biopharma (RDHL)	Israel	$0.147B	0.00
IMV INC (IMV)	Canada	$0.140B	0.00
Ardelyx (ARDX)	United States	$0.135B	0.00
GlycoMimetics (GLYC)	United States	$0.132B	0.00
Jounce Therapeutics (JNCE)	United States	$0.130B	0.00
Generex Biotechnology (GNBT)	United States	$0.128B	0.00
Majesco Entertainment (PTE)	United States	$0.119B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.117B	0.00
ALLERGY THERAPT (AGYTF)	United Kingdom	$0.108B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.107B	0.00
MEI Pharma (MEIP)	United States	$0.106B	0.00
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.104B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.098B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.094B	0.00
Mast Therapeutics (SVRA)	United States	$0.092B	0.00
Aquestive Therapeutics (AQST)	United States	$0.088B	0.00
Neos Therapeutics (NEOS)	United States	$0.088B	0.00
Cardiome Pharma (CORV)	Canada	$0.085B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.085B	32.41
Genocea Biosciences (GNCA)	United States	$0.082B	0.00
Natural Alternatives (NAII)	United States	$0.076B	7.62
RENEURON GP (RNUGF)	United Kingdom	$0.075B	0.00
MediWound (MDWD)	Israel	$0.074B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.074B	0.00
Nivalis Therapeutics (ALPN)	United States	$0.071B	0.00
Champions Oncology (CSBR)	United States	$0.069B	598.00
Infinity Pharmaceuticals (INFI)	United States	$0.068B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.068B	0.00
Otonomy (OTIC)	United States	$0.067B	0.00
Novan (NOVN)	United States	$0.065B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.063B	0.00
Pharmaxis (PXSLY)	Australia	$0.060B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.059B	0.00
SCYNEXIS (SCYX)	United States	$0.058B	0.00
Capnia (SLNO)	United States	$0.057B	0.00
Lipocine (LPCN)	United States	$0.053B	0.00
Medicure (MCUJF)	Canada	$0.053B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.053B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.046B	0.00
ElectroCore (ECOR)	United States	$0.045B	0.00
Forward Pharma (FWP)	Denmark	$0.044B	0.00
CTI BioPharma (CTIC)	United States	$0.038B	0.00
Mannatechorporated (MTEX)	United States	$0.036B	0.00
Bio-Path Holdings (BPTH)	United States	$0.035B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.033B	0.00
Melinta Therapeutics (MLNT)	United States	$0.032B	0.00
PharmAthene (ALT)	United States	$0.032B	0.00
Biomerica (BMRA)	United States	$0.030B	0.00
ProPhase Labs (PRPH)	United States	$0.023B	0.00
Opexa Therapeutics (ACER)	United States	$0.020B	0.00
Heat Biologics (HTBX)	United States	$0.019B	0.00
Summit Therapeutics (SMMT)	United Kingdom	$0.018B	1.43
HANCOCK JAFFE (HJLI)	United States	$0.017B	0.00
Tetraphase Pharmaceuticals (TTPH)	United States	$0.015B	0.00
Achieve Life Sciences (ACHV)	United States	$0.014B	0.00
Cyanotech (CYAN)	United States	$0.014B	0.00
Onconova Therapeutics (ONTX)	United States	$0.014B	0.00
Shineco (TYHT)	China	$0.013B	0.00
Regulus Therapeutics (RGLS)	United States	$0.012B	0.00
Kitov Pharmaceuticals Holdings (KTOV)	Israel	$0.011B	0.00
VAXART, INC (VXRT)	United States	$0.010B	0.00
Eyegate Pharmaceuticals (EYEG)	United States	$0.009B	0.00
RXi Pharmaceuticals (PHIO)	United States	$0.009B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.007B	0.00
Jaguar Animal Health (JAGX)	United States	$0.006B	0.00
Flex Pharma (SLRX)	United States	$0.004B	0.00
Midatech Pharma (MTP)	United Kingdom	$0.004B	0.00
Cytori Therapeutics Inc (PSTV)	United States	$0.002B	0.00
Xenetic Biosciences (XBIO)	United States	$0.001B	0.00
Advanced Accelerator Applications S.A (AAAP)	France	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00